chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 7 minutes, the patient developed difficulty breathing, scratchy throat, cough, hives, chest tightness, nausea and lightheadedness. She was transferred to the Emergency Department within 5 minutes and was treated with Benadryl, Pepcid, Methylprednisolone, and another medication that she is not able to remember.
Family reported temp 101, lethargy, agitation for 2-3 days, starting 2-3 days after immunization. Was seen in office 11/21/2005 - afebrile; family reported "downhill" from there, no cause of fever/infection identified; continued WBC decreased.
pt had rxn where eyes got swollen & red & also vomiting;pt given epi 11:37AM;
This is a spontaneous report from a non-contactable nurse (the patient). A patient of unspecified age, gender and ethnicity received on the same day (date unknown) PREVNAR 13 at a single dose  and flu vaccine (manufacturer unknown) at an unknown dose both via an unspecified route of administration, on unknown date. Relevant medical history myelodysplastic syndrome, ongoing. Concomitant medications were not reported. The day after the vaccination, hemoglobin went from 8.7 to 6.9 (unit not provided) and he/she was not feeling well. The patient had a transfusion for hemoglobin decreased. The outcome of the events was unknown. No follow up attempts possible. No further information expected.
Crying, grabbing throat, excessive sleeping. Would not eat and vomiting. Blood in Pamper.
After the first shot, I was not felling well, but not ill, as i could not tell what was wrong with me. I lost my appetite, but i still could eat.  A week after the second shot, I totally lost my appetite and could not eat anything, or sleep. I lost 10 ponds in a month, 6 pounds following the second dose. My doctor ordered ultra sound of abdominal area, and results were normal.  My white Blood count was slightly high mostly high in Lymphocytes.  The WBC came back normal the following week.  My doctor prescribed Mitrazopine (15 mg) to correct for lose of appetite and to sleep.  I felt back to normal about a week later.
Per mother's request - 6/2/08 numbness lower legs.  6/12/08 blurry vision left eye - Optic Neuritis.  6/21/08 numbness shoulder.  09/19/2008 MR received for DOS 6/23-26/08 with Final DX: Suspected Multiple Sclerosis vs ADEM. Left Optic Neuritis.  Pt transfered to current facility with recent dx of Optic Neuritis and brain MRI concerning for MS. Pt developed blurry vision and was seen and dx by ophthamologist. Pt had been experiencing blurry vision. Now experiencing numbness of the L side wrapping around to the back and numness of both 1st toes. PE (+) for decreased strength LUE. Tx with IV solumedrol. D/C for outpt f/u. 1/27/2010 She has been diagnosed with MS.
Tuesday, rash started on Wed with no new meds/food/lotion/soap/detergent.  Rash is raised, wide-spread to left arm, abdomen and upper back/shoulders.  + Itching/irritation. Denies blistering, SOB, cough, fever, chills.  Using topical triamcinolone which helps with itching START ON Prednisone for 9 days, Claritin 10mg AM for 7 days,Benadryl 25-50mg PM for 7 days.
Developed Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the dose of Shingrix and developed Shingles. The follow up consent was granted. As date of birth was future date which was discrepant hence clarification raised for DOB considering age group as adult.
Pt reports "head cold" w/ h/a, some rhinits, some prod cough- pressure is most bothersome.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in a 47-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent vaccination included tdap (non-gsk); non-GSK manufacturer given on 19 January 2010. On 19 January 2010, 22 February 2010 and 19 July 2010 the subject received 1st dose, 2nd dose and 3rd dose of ENGERIX B (1 ml, unknown route, unknown deltoid). On 30 August 2010, 42 days after the 3rd vaccination with ENGERIX B, 6 months after the 2nd vaccination with ENGERIX B, and 7 months after the 1st vaccination with ENGERIX B, the subject experienced not responding to therapy. The subject's titers were drawn on 30 August 2010 and were negative. The vaccination series was repeated. On 4 October 2010, 5 November 2010 and 7 April 2011 the subject received 4th dose, 5th dose and 6th dose of ENGERIX B (1 ml, unknown route, unknown deltoid). On 21 May 2011, 44 days after the 6th vaccination with ENGERIX B, 6 months after the 5th vaccination with ENGERIX B, and 8 months after the 4th vaccination with ENGERIX B, the subject experienced not responding to therapy. The subject's titers were drawn on 21 May 2011 and were 1.8 (units not provided). This case involves a pharmaceutical product complaint. The healthcare professional reported that she had seen an increase in non-responders to vaccination with ENGERIX B and was concerned about the vaccine. It was noted that all the vaccines are monitored by several methods for temperature excursions. The healthcare professional reported 7 cases of not responding to therapy following Hep B vaccination. This is case 1 of 7 (see case IDs A0947239A-A0947244A for details of the other reports). Follow-up received from the reporting healthcare professional on 18 October 2011: On 30 August 2010, the subject's hepatitis B surface antibody was 0.24 mIU/mL (immunity was noted by the healthcare professional as greater than 0.99). On 19 May 2011 (after the 2nd series of ENGERIX B), 42 days after the 6th vaccination with ENGERIX B, 6 months after the 5th vaccination with ENGERIX B, and 7 months after the 4th vaccination with ENGERIX B, the subject's hepatitis B surface antibody was 1.89 mIU/mL. All 6 doses of ENGERIX B were administered intramuscularly in the left deltoid.
Underage patient received Pfizer vaccine. No adverse reactions noted. No problems at present or after first vaccine.
Red, swollen area that was warm to touch. about 5 inches in diameter. recommended Benadryl every 6-8 hours, PRN and started patient on Keflex suspension BID x 7 days
Vaccine administer after puncturing more than 20 times; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Vaccine administer after puncturing more than 20 times) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Nov-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Vaccine administer after puncturing more than 20 times). On 10-Nov-2021, PRODUCT ADMINISTRATION ERROR (Vaccine administer after puncturing more than 20 times) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported.  No treatment information was reported by the reporter.  Pharmacist stated that they had 14 vials of Moderna COVID-19 vaccine that was punctured more 20 times in order to administer the dose to the patient. The vial did not undergo any temperature excursion.
Enlarged spleen.  Increased liver enzymes.  Fever.  Painful injection site.  Knot at injection site.  Heat at injection site.  Redness at injection site.
unable to lift the left arm up (only about halfway); mild, constant pain in left arm/stung really bad; fever up 102F; Initial information received on 26-Sep-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 48 years old male patient who experienced fever up 102f (pyrexia), mild, constant pain (pain in extremity) in left arm/stung really bad and unable to lift the left arm up (only about halfway) (movement disorder), while he received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.   On 24-Sep-2019, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via intramuscular route in the left deltoid.  On 24-Sep-2019, The patient developed a non-serious fever up 102f (pyrexia) few hours following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  On an unknown date, The patient developed a non-serious mild, constant pain in left arm/stung really bad (pain in extremity) and unable to lift the left arm up (only about halfway) (movement disorder) Unknown latency following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Body temperature - On 24-Sep-2019: 38.8 Cel [38.8]  Final diagnosis was fever up 102f, unable to lift the left arm up (only about halfway) and mild, constant pain in left arm/stung really bad.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Recovered / Resolved on an unknown date for fever up 102f, as Unknown for mild, constant pain in left arm/stung really bad and as Unknown for unable to lift the left arm up (only about halfway).  Information on the batch number was requested.
pt recv vax 14DEC98 & pt devel pneumonia & was hosp;no cult were performed & the causative organism was not identified;pt died on 12FEB99;this is 1 of 5 resident, out of 54 vaccinated who devel pneumonia p/pnu-immune 23 vax;
very weak and almost passed out on Wednesday; very weak and almost passed out on Wednesday; joint pain; body aches; chills; extreme fatigue; very lethargic; pain that ran down my arm up into neck; pain that ran down my arm up into neck; This is a spontaneous report from a contactable Nurse. A patient of unspecified age and gender(Age: 59, Unit: Unspecified) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 and experienced fatigue sore arm. After shot 2, the patient experienced joint pain, body aches, chills, extreme fatigue and very lethargic, pain that ran down my arm up into neck. The patient got shot on Monday, symptoms were on Tuesday, the patient was very weak and almost passed out on Wednesday. The patient did not have COVID 19 before and did not take paracetamol(TYLENOL). The outcome of the events was unknown.     Information on the Lot/Batch number has been requested.
This was my second bivalent vaccine - my sixth Moderna vaccine. My arm felt a little stiff the night of the vaccine. I took of sweatshirt at 5 pm 5/2 and my upper arm down to approximately 2.5 inches above my elbow was red and the arm was incredibly swollen and flesh was hard. It was not limited to the area local to the injection site.
Fingers tingling in vaccinated arm, vomiting , diarrhea, nausea, numbness in both arms
Mild headache; tiredness was mild also; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration, administered in the left arm on 10Mar2021 13:00 (at the age of 64-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included Diabetic and high BP. The patient received unspecified medication/s within 2 weeks of vaccination. The patient previously took naproxen (reported as naproxyn) and experienced drug hypersensitivity. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced mild headache and tiredness was mild also on 11Mar2021 08:00. No treatment was received as a result of the events. Patient did not seek consult to physician or urgent care. The outcome of events was recovered on an unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A nurse reported that a female subject of unspecified age did not respond to immunization with hepatitis B vaccine recombinant (Engerix-B). The subject's medical history, concurrent conditions, and concurrent medications were not reported.  The subject received her first and second injections of Engerix-B on unspecified dates.  Lot ENG5285A6 was used for both injections.  On 11/01/02, the subject received her third injection of Engerix-B (Lot # ENG5312A6).  On 05/05/03, an unspecified titer was "negative".
Patient indicates they began having symptoms 2 days after receiving the flu vaccination. They said flu like symptoms occurred after the vaccination as well as atrial fib, increased heart rate, fever, high white blood cell count, headache, chills, and weak legs and stated they went to the ER for symptoms.
Day of injection uncontrollable diarrhea for 36 hours  Saturday and Sunday night- nausea , abdominal pain, Sunday I starting  vomiting  Monday went to the hospital
This spontaneous report as received from healthcare worker refers to a 14 year old patient of unknown gender. No information on their medical history, concurrent conditions or concomitant drugs was provided. The patient was vaccinated with doses of VARIVAX (Merck) subsequently on 05-DEC-2000, 11-JUL-2011 and 26-SEP-2014 (doses, routes and sites of injection, lot# and expiration dates unknown). No adverse symptoms were reported. Additional information has been requested.
Facial twitches and numbness (mild, on and off) on side vaccine was given. Warm feeling in throat and metal taste in mouth (both of these have gone). Twitches and mild numbness still happening.
Patient reported hives that come and go that started when they got the booster. They are still ongoing today.
Within 10 hours of vaccine administration, area of DTaP injection with large amount erythema noted.  Today, on 3/4/2004, 24 hours after injection, there is 11x12 cm of erythema, swelling, erythema, subcutaneous edema, with single blister noted. Arm circumference at axilla right 19cm, left 24.5 cm. Midhumeral circumference 16.5 cm on the right, 21 cm on the left. Arm is painful and child resists touching or moving the left shoulder. Mom felt that his face was puffy when he woke up this morning. There was no swelling or redness or induration at the sites of the IPV or MMR vaccines.
Dizziness & Headache Narrative: Employee informed this RN that he "I feel like I'm going to faint and I have a headache". 0910-BP 121/73, HR 52 O2 sat 97% 0915-Employee states "I still feel faint". 0930-Eployee still states he feels faint and like he is going to pass out. Code assist called. 0935-120/76 HR-51. 0940-Employee still feeling faint, assisted to ER by ER staff via W/C for full evaluation.
I do have a history of Migraines but they were well controlled. Thirteen weeks after getting the second dose of the vaccine I started to get what I thought was a Migraine. It was my whole head and neck. It lasted for several weeks but my normal medication did not work. I went to visit my doctor 06/04/2021 after I had a low grade fever and some High Blood Pressure for one and a half weeks.. I was treated for Meningitis with Gabapentin and Valtrex but there was no improvement. I ended up being hospitalized but all tests were negative. I have had injection as a Nerve Block but that did not work. I still have the nagging headache after 14 weeks and none of the treatments worked. It lasts all day and gets worse toward the end of the day and at the end of the week. The most intense pain is at the base of my head in the back.
Have had a steady period since at least the 2nd shot. The period started very heavy with clots, and has been thin but steady for the past 2-3 weeks.
pt recv vax 22APR96 & 23APR96 pt exp inflammation @ the inj site, fever of 103, flu-like pain in joints arthritic pain;
Hives in the arm/hives all over the body; Bad rash in the arm/bad rash all over the body; Did not got a 2nd dose, due to previous symptoms with 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (Hives in the arm/hives all over the body), RASH (Bad rash in the arm/bad rash all over the body) and PRODUCT DOSE OMISSION ISSUE (Did not got a 2nd dose, due to previous symptoms with 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives in the arm/hives all over the body), RASH (Bad rash in the arm/bad rash all over the body) and PRODUCT DOSE OMISSION ISSUE (Did not got a 2nd dose, due to previous symptoms with 1st dose). At the time of the report, URTICARIA (Hives in the arm/hives all over the body) and RASH (Bad rash in the arm/bad rash all over the body) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Did not got a 2nd dose, due to previous symptoms with 1st dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient experienced a bad rash and hives on his arm and all over his body. No concomitant medications were given. No treatment information was given.   Reporter did not allow further contact
Developed weakness on legs the day vax received. Continued w/weakness of legs, no strength in legs. Saw an internist. Sx's persisted and became worse on 1/14/03. Was able to see neurologist another day following internist visit. States that an MD told her that the weakness of legs is probably due to the flu shot. Being treated w/meds and PT 3x week.
soft at the injection site; itchy at the injection site; tender at the injection site; swollen at the injection site; a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a sore arm), SOFT TISSUE MASS (soft at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (tender at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), MONTELUKAST SODIUM (SINGULAIR), VORTIOXETINE, GABAPENTIN, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION) and MONTELUKAST for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (a sore arm). On 05-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (tender at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site). On an unknown date, the patient experienced SOFT TISSUE MASS (soft at the injection site). On 26-Mar-2021, PAIN IN EXTREMITY (a sore arm) had not resolved. At the time of the report, SOFT TISSUE MASS (soft at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (tender at the injection site) and VACCINATION SITE SWELLING (swollen at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications OTC Benadryl when needed  No treatment product information was provided
Pt received Kinrix & proquad on 4/22/19. Pt came in the next day with redness on left deltoid. VIS was given before vaccination.
Next day patient experienced headache, flu-like symptoms, pain and hot red rash on arm where injection received. Two weeks later she broke out in a "shingles" like rash with burning on her arms and neck. She had ear pain which she was examined for and told it was a nerve pain.
FEVER 102F, SEVERE PAIN AT SIGHT (RT DELTOID) SWOLLEN AROUND NECK, DIZZINESS, WEAKNESS AND SORE THROAT. SHE SAID SHE WAS TOO WEAK TO EVEN GO TO THE HOSPITAL...
Erythema 2 inches below vaccination site with tenderness and hotness. Possible cellulitis.
Received 1st Shot 4/10/21.  A few days after 1st Shot of Pfizer: My eczema flared up and I was waking up from itching in the middle of the night. I was being treated for eczema for a few months prior to vaccination. I had never woken up from itching prior to vaccination. Flare up areas were on shoulder opposite of vaccination arm. This area had never flared up before. Also had period of flare up behind right knee for first time as well. All of these were more severe than before vaccination.  I used topical steroids sparingly in the few weeks after 1st Dose. After 3rd week it seemed to ease.  Received 2nd Shot 5/1/21.  After 2nd Shot of Pfizer: I had Tinnitus side effect in both ears seemingly from the vaccine. I did not have worsening skin rashes/eczema after 2nd Dose.I did not have Tinnitus after 1st dose.  2 weeks later, symptoms seem less but not completely gone. Eczema is similar to what it was before both vaccine doses.
I started having pain in my middle and stiffness in my hands while I was trying to do my gardening. I had an appointment with my rheumatologist. She had ordered physical therapy, steroid shots. None of this helped. I was referred to a hand specialist where it was discovered that I had trigger finger and I had to have surgery to resolve the issue. I am now in recovery as it takes 8 to 10 weeks for recovery.
Redness and warmth around injection site spread around upper arm for next 24 hours, had not spread overnight and reported to pharmacy on morning of 5/6/17, took BENADRYL at bedtime on 5/6/17 and pharmacy followed up on 5/7/17 at 12:30pm and patient reported site was not as red, no longer warm to touch and area had reduced some.
Dose of Janssen vaccine was administered 1 hour after the beyond use date. Vial was punctured at 1653PM and stored at RT, labeled with two hour BUD. Dose from this vial was administered to the patient at 1933. The patient has had no adverse outcomes from this event.
inconsolable crying, began approx 1-2hr p/vax;mom was instructed to return to clinic @ which time pt was quieter, clam, consolable;f/u phone call 6NOV96 revealed negative sx;
Left thigh swollen, erythematous warm to touch.  Treated with Keflex, Benadryl 1% hydrocortisone.